Total pendapatan perusahaan Chimerix (CMRX)

Lambang korporat lan logo Chimerix Inc. (CMRX)

Chimerix, Inc. (CMRX) sales dynamics show a performance metric of 0.00. Management has shifted its strategic focus toward combating gliomas while optimizing costs. Revenue is based on US government biodefense contracts and oncology centers. The primary growth driver will be the final Phase 3 trial data for ONC201, while investors have already priced in current operating expenses.

CMRX - Pendapatan perusahaan Chimerix ing rentang 04.07.2022 - 26.04.2025

Rincian analitis perusahaan Chimerix (CMRX)

- nilai saham lan prakiraan konsensus rega:
Kutipan saham Chimerix Inc|CMRX - Bagan rega target
- rincian kapitalisasi pasar:
Nilai pasar Chimerix, Inc.|CMRX - Nilai Total Perusahaan
- indikator nilai buku ekuitas:
Aset Bersih saben Siji Saham Chimerix|CMRX - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku chimerix.com|CMRX - Total Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Rasio Utang marang Modal Chimerix, Inc.|CMRX - Rasio utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Chimerix Inc.|CMRX - Gunggung utang perusahaan|Rasio utang marang aset resik Chimerix, Inc.|CMRX - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Chimerix|Rasio jangkoan perantara chimerix.com
- statistik bathi lan rasio pasar:
CMRX - Bathi resik|Bathi resik sing dikarepake Chimerix, Inc.|CMRX - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi chimerix.com|CMRX - Pangali PEG|Pangali EV/EBITDA Chimerix, Inc.|CMRX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Chimerix|CMRX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan chimerix.com|CMRX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Chimerix, Inc.
- indikator volume dodolan lan pendapatan:
CMRX - Pendapatan lan volume dodolan|Pendapatan mangsa ngarep perusahaan Chimerix Inc|CMRX - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake Chimerix, Inc.
Analisis umum perusahaan:Chimerix Inc - CMRX
Produk seri Chimerix, Inc.

The virtual business model of Chimerix, Inc. (CMRX), which utilizes outsourcing to cGMP plants for production, minimizes capital expenditures by focusing resources on clinical trials. By analyzing the company's sales dynamics, investors track daily liquidity inflows, allowing for a real-time assessment of market demand and confirmation of the business model's viability, thereby protecting investment capital from the risks of technological obsolescence.

Perusahaan pesaing

Dodolan perusahaan Incyte Pharma (INCY)|Pendapatan perusahaan HUTCHMED (China) Limited (HCM)|NUVB - Total pendapatan perusahaan|Pendapatan perusahaan Day One Biopharmaceuticals DAWN|Monopar Therapeutics Inc - Pendapatan perusahaan|INBX - Pendapatan perusahaan|Total pendapatan perusahaan I-Mab|FENC: Pendapatan lan volume dodolan|Total volume dodolan perusahaan Heron Therapeutics, Inc. HRTX|Dodolan perusahaan NVCT|Total pendapatan perusahaan Coherus BioSciences Inc. CHRS|Dodolan perusahaan CRBP (Corbus Pharma)|CRDF (cardiffoncology.com) - Pendapatan dodolan perusahaan|BeyondSpring Inc. - Dodolan perusahaan|Total dodolan perusahaan BCAB (BioAtla Inc)|Lixte Biotechnology Holdings, Inc. - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan CTXR (Citius Pharmaceuticals)|CLRB: Pendapatan lan volume dodolan|Total pendapatan perusahaan BioLineRx Corporation (BLRX)|Pendapatan perusahaan Can-Fite BioPharma|APRE: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan KZIA|Pendapatan lan volume dodolan silexion.com (SLXN)|Pendapatan perusahaan NuCana NCNA|CYCC (Cyclacel, Inc.) - Pendapatan tahunan perusahaan|GTHX: Dodolan perusahaan|Total pendapatan perusahaan kronosbio.com|KTRA: Pendapatan lan volume dodolan|Dodolan perusahaan Oncternal Therapeutics Inc|PRTG (Portage) - Pendapatan lan volume dodolan